Advances in Therapeutic Approaches to Extend Healthspan: a perspective from the 2nd Scripps Symposium on the Biology of Aging

Research output: Contribution to journalComment/debate

6 Citations (Scopus)

Abstract

The 2nd Scripps Florida Symposium on The Biology of Aging entitled ‘Advances in Therapeutic Approaches to Extend Healthspan’ was held on January 22nd–25th, 2017 at The Scripps Research Institute in Jupiter, Florida. The meeting highlighted a variety of therapeutic approaches in animal models of aging that either are or soon will be in clinic trials. For example, drugs targeting senescent cells, metformin, rapalogs, NAD precursors, young plasma, mitochondrial-targeted free radical scavengers, stem cells, and stem cell factors all have shown significant preclinical efficacy. This perspective, based on presentations and discussions at the symposium, outlines the current and future state of development of therapeutic approaches to extend human healthspan.

Original languageEnglish (US)
Pages (from-to)610-614
Number of pages5
JournalAging cell
Volume16
Issue number4
DOIs
StatePublished - Aug 2017
Externally publishedYes

Fingerprint

Free Radical Scavengers
Stem Cell Factor
Metformin
Drug Delivery Systems
NAD
Stem Cells
Therapeutics
Animal Models

Cite this

@article{a4b0a6acbc704435b8209422039cdc62,
title = "Advances in Therapeutic Approaches to Extend Healthspan: a perspective from the 2nd Scripps Symposium on the Biology of Aging",
abstract = "The 2nd Scripps Florida Symposium on The Biology of Aging entitled ‘Advances in Therapeutic Approaches to Extend Healthspan’ was held on January 22nd–25th, 2017 at The Scripps Research Institute in Jupiter, Florida. The meeting highlighted a variety of therapeutic approaches in animal models of aging that either are or soon will be in clinic trials. For example, drugs targeting senescent cells, metformin, rapalogs, NAD precursors, young plasma, mitochondrial-targeted free radical scavengers, stem cells, and stem cell factors all have shown significant preclinical efficacy. This perspective, based on presentations and discussions at the symposium, outlines the current and future state of development of therapeutic approaches to extend human healthspan.",
author = "Robbins, {Paul D.} and Niedernhofer, {Laura J.}",
year = "2017",
month = "8",
doi = "10.1111/acel.12620",
language = "English (US)",
volume = "16",
pages = "610--614",
journal = "Aging Cell",
issn = "1474-9718",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Advances in Therapeutic Approaches to Extend Healthspan

T2 - a perspective from the 2nd Scripps Symposium on the Biology of Aging

AU - Robbins, Paul D.

AU - Niedernhofer, Laura J.

PY - 2017/8

Y1 - 2017/8

N2 - The 2nd Scripps Florida Symposium on The Biology of Aging entitled ‘Advances in Therapeutic Approaches to Extend Healthspan’ was held on January 22nd–25th, 2017 at The Scripps Research Institute in Jupiter, Florida. The meeting highlighted a variety of therapeutic approaches in animal models of aging that either are or soon will be in clinic trials. For example, drugs targeting senescent cells, metformin, rapalogs, NAD precursors, young plasma, mitochondrial-targeted free radical scavengers, stem cells, and stem cell factors all have shown significant preclinical efficacy. This perspective, based on presentations and discussions at the symposium, outlines the current and future state of development of therapeutic approaches to extend human healthspan.

AB - The 2nd Scripps Florida Symposium on The Biology of Aging entitled ‘Advances in Therapeutic Approaches to Extend Healthspan’ was held on January 22nd–25th, 2017 at The Scripps Research Institute in Jupiter, Florida. The meeting highlighted a variety of therapeutic approaches in animal models of aging that either are or soon will be in clinic trials. For example, drugs targeting senescent cells, metformin, rapalogs, NAD precursors, young plasma, mitochondrial-targeted free radical scavengers, stem cells, and stem cell factors all have shown significant preclinical efficacy. This perspective, based on presentations and discussions at the symposium, outlines the current and future state of development of therapeutic approaches to extend human healthspan.

UR - http://www.scopus.com/inward/record.url?scp=85020221381&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020221381&partnerID=8YFLogxK

U2 - 10.1111/acel.12620

DO - 10.1111/acel.12620

M3 - Comment/debate

C2 - 28585366

AN - SCOPUS:85020221381

VL - 16

SP - 610

EP - 614

JO - Aging Cell

JF - Aging Cell

SN - 1474-9718

IS - 4

ER -